Trials / Withdrawn
WithdrawnNCT04117373
Mohs Micrographic Surgery and Reconstruction in the Optum Insurance Claims Database
Characterizing Trends in Mohs Micrographic Surgery and Complex Reconstruction in the Optum Healthcare Population
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 1 Year – 99 Years
- Healthy volunteers
- —
Summary
Mohs micrographic surgery (MMS) followed by skin reconstruction has been widely accepted for treatment of many skin cancers. To further characterize the trends in MMS and reconstruction for skin cancer, a retrospective analysis will be performed using the Optum© Clinformatics® DataMart de-identified commercial claims database from 2001-2016. The findings may provide critical data for future prospective studies in skin cancer treatments.
Conditions
Timeline
- Start date
- 2019-07-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2019-10-07
- Last updated
- 2020-03-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04117373. Inclusion in this directory is not an endorsement.